安旭生物(688075.SH)：股东马华祥拟减持合计不超过120万股股份

Core Viewpoint - Anxu Bio (688075.SH) announced that shareholder Ma Huaxiang plans to reduce his stake in the company due to personal funding needs, with a maximum reduction of 1.2 million shares, representing 0.94% of the total share capital [1] Summary by Sections - Shareholder Reduction Plan - Ma Huaxiang intends to reduce his holdings through centralized bidding, with the total number of shares reduced not exceeding 1.2 million [1] - The reduction will not exceed 1.00% of the company's total shares within any consecutive 90-day period [1] - Timing and Pricing - The reduction period will commence 15 trading days after the announcement and will last for three months [1] - The selling price will be determined based on market conditions [1]